News

Virginia Companies Expand into Global Markets through Commonwealth’s Trade Accelerator Program

Governor Glenn Youngkin today announced that 16 companies across the Commonwealth have graduated from the Virginia Economic Development Partnership’s (VEDP) Virginia Leaders in Export Trade (VALET) program and 13 companies have joined the two-year program. VALET, which now has 391 graduated companies, assists Virginia exporters that have firmly established domestic operations and are committed to international exporting as a growth strategy.

“International trade is a pillar of the Commonwealth’s economy, and the VALET program provides invaluable resources to guide Virginia businesses seeking growth into the global marketplace,” said Governor Glenn Youngkin. “We congratulate these companies that have grown their domestic sales and are taking the next steps toward international expansion, advancing Virginia’s economic growth in diverse regions of the Commonwealth.”

“The VALET program has facilitated access to global markets for businesses of any size or sector over the past two decades, helping nearly 400 Virginia companies successfully expand their international sales,” said Secretary of Commerce and Trade Caren Merrick. “This award-winning program can be transformational as a growth strategy and provides long-term economic benefits for these businesses and the Commonwealth as a whole.”

The graduating companies are:

  • Aeronautical Systems, Inc. (Fairfax County)
  • Alacran Consulting (Montgomery County)
  • ANRA Technologies (Fairfax County)
  • Atlantic Research Group (Albemarle County)
  • Axxor N.A. LLC (Pittsylvania County)
  • Babylon Micro-Farms (City of Richmond)
  • Black Dog Salvage (City of Roanoke)
  • Bloomaker USA Inc. (Augusta County)
  • Elgin Separation Solutions (Tazewell County)
  • NAG Marine (City of Norfolk)
  • QualiChem (City of Salem)
  • RangeForce (Prince William County)
  • River Front Services (Fairfax County)
  • SimIS, Inc. (City of Portsmouth)
  • SteelMaster Buildings (City of Virginia Beach)
  • The Virginia Beer Company (York County)

VALET is a two-year international business acceleration program that provides participating companies with international sales plan development services, assistance from a team of experienced international service providers, international business meetings with potential partners, educational events, and customized market research. There are currently 49 companies participating in the VALET program and 441 Virginia companies have been accepted to participate in the program since its inception in 2002.

The companies joining the VALET program include:

  • Afton Scientific Corporation (Albemarle County)
  • AQ Transformer Solutions (Wythe County)
  • BluePrint Automation (Chesterfield County)
  • Damon Company (City of Salem)
  • DataXstream, LLC (James City County)
  • DZYNE Technologies (Fairfax County)
  • Fabritek Company, Inc. (City of Winchester)
  • Learning Tree International (Fairfax County)
  • Parsons Government Services (Fairfax County)
  • Regulus Global (City of Virginia Beach)
  • Universal Fibers (Washington County)
  • Vibrent Health (Fairfax County)
  • Yupo Corporation (City of Chesapeake)

“When Virginia companies succeed overseas, it further cements the Commonwealth’s position as a key player in the global marketplace and underscores the value of VEDP’s world-class VALET program,” said Jason El Koubi, VEDP President and CEO. “We are excited to see the outcomes that these Virginia businesses will achieve—including substantial trade-supported job creation in Virginia—as a result of their participation in the program.”

Virginia exports over $51 billion in goods and services annually. Exports of the Commonwealth’s products and services are critical to economic growth, supporting more than 257,000 jobs and generating $2 billion in annual tax revenue. VEDP offers numerous programs to assist Virginia companies with selling into the global marketplace and has a network of international market research consultants covering 122 countries around the globe.

The Virginia Economic Development Partnership was created by the Virginia General Assembly in 1995 to encourage, stimulate, and support the development and expansion of the economy of the Commonwealth. To accomplish its objectives of promoting economic expansion within the Commonwealth, the Partnership focuses its efforts on business recruitment, expansion, and international trade development.

 

More information on the VALET Program is available here.

Recent News

10/23/2026

PAK BioSolutions and iBET Advance Integrated Continuous AAV8 Purification

PAK BioSolutions today announced the publication of a peer-reviewed study on integrated, continuous purification of adeno-associated virus serotype 8 (AAV8) using the PAK PD™ Process Development Scale Continuous Purification System. Conducted in collaboration with iBET – Instituto de Biologia Experimental e Tecnológica, the study, “Streamlining AAV8 Purification with Cyclic Integrated Capture–Polishing Chromatography,” was published in …

10/22/2026

Lilly breaks ground in Richmond to expand American manufacturing of next-generation cancer medicines, advancing its build-out of 10 new U.S. sites since 2020

Eli Lilly and Company (NYSE: LLY) broke ground today on a new $5 billion manufacturing facility just west of Richmond, Virginia, in Goochland County, one of 10 new U.S. manufacturing sites announced since 2020 and one of five among them that will produce active pharmaceutical ingredients (API). As part of the company’s more than $50 …

10/21/2026

United Therapeutics Expands Organ Manufacturing Capabilities with Opening of Third Designated Pathogen-Free Xenograft Production Facility

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced the opening of its third Designated Pathogen-Free (DPF) facility, The Dr. Bartley P. Griffith and Dr. Robert A. Montgomery Xenograft Production Facility, in Houston, Texas. United Therapeutics opened its first DPF facility in Christiansburg, Va. in 2024 to produce xenografts for ongoing clinical trials. …